Pfizer CEO in talks with 90 countries for Covid-19 pill
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[LOS ANGELES] Pfizer is in discussions with 90 countries over supply contracts for its experimental Covid-19 pill, which was shown to reduce by 89 per cent the risk of hospitalisation or death in patients at high risk of severe illness, chief executive officer Albert Bourla said in an interview on Friday (Nov 5).
He said Pfizer expects to price its treatment, called Paxlovid, close to where rival Merck & Co has priced its oral antiviral drug candidate.
Merck's US contract price for its pill molnupiriavr is around US$700 for a 5-day course of therapy.
REUTERS
READ MORE: Pfizer says Covid pill 89% effective against severe disease
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
